AnalyzeDirect

Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy

Kentaro Hirade et al. Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy Cell Reports Medicine. Publication Date August 29, 2025 How Analyze was Used “Tumor volume was evaluated by CT imaging twice weekly. CT imaging was performed…and tumor volume was evaluated by Analyze 12.0 software…